|
EP1789078A1
|
|
Pulmonary delivery of a nerve agent neutralizing enzyme
|
|
US7057023B2
|
|
Methods and apparatus for spinning spider silk protein
|
|
AU2003202330A1
|
|
Recovery of biofilament proteins from biological fluids
|
|
AU2003201513A1
|
|
Methods of producing silk polypeptides and products thereof
|
|
AU2002353374A1
|
|
Production of butyrylcholinesterases in transgenic mammals
|
|
WO0219811A2
|
|
Generation of transgenic animals using nuclear transfer and oocytes at the germinal vesicle stage
|
|
EP1251888A1
|
|
Surgical sutures containing spider silk
|
|
AU1441301A
|
|
Transgenic animal production using lopu-derived oocytes
|
|
WO0132854A1
|
|
Production of transgenic animals using nuclear transfer and oocytes recovered by lopu
|
|
WO0111950A1
|
|
Transgenic animals that produce altered wool
|
|
WO0015772A2
|
|
Recombinant protein production in urine
|
|
US7157615B2
|
|
Production of biofilaments in transgenic animals
|
|
AU5775798A
|
|
Beta-galactosidase with reversibly inactive lactase activity
|
|
US5907080A
|
|
Method for development of transgenic dwarf goats
|
|
US5821350A
|
|
Aspergillus niger beta-galactosidase gene
|
|
US5780009A
|
|
Direct gene transfer into the ruminant mammary gland
|
